Katey Einterz Owen is Director of Adaptive Biotechnologies Corp. Currently has a direct ownership of 57,235 shares of ADPT, which is worth approximately $252,978. The most recent transaction as insider was on Mar 04, 2024, when has been sold 31,328 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.2K
0% 3M change
120.92% 12M change
Total Value Held $252,978

KATEY EINTERZ OWEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2024
BUY
Grant, award, or other acquisition
-
31,328 Added 35.37%
57,235 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
14,775 Added 36.32%
25,907 Common Stock
Jan 26 2022
BUY
Grant, award, or other acquisition
-
6,689 Added 37.53%
11,132 Common Stock
Mar 17 2021
BUY
Grant, award, or other acquisition
-
4,443 Added 50.0%
4,443 Common Stock
KEO

Katey Einterz Owen

Director
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT